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Chronic Obstructive Pulmonary Disease (COPD) and Emergency Departments: 
The Impact of Attributing a General Practitioner 
 
 
Abstract 
With an increasing prevalence of chronic diseases, people are experiencing more 
emergency episodes. Chronic Obstructive Pulmonary Disease (COPD) will be, by 2020, the 
third leading cause of death and its acute exacerbations will pose major challenges on primary 
and secondary health care management. This study uses a database comprising all emergency 
admissions between 2014 and 2015. A probit model is estimated to assess the impact of 
different factors on the probability of being a frequent user. Results show it increases (within 
COPD patients) for men, with 80+ years of age and an assigned General Practitioner. These 
patients are vulnerable and will need timely access to health care. Accordingly, the creation of 
health policies, such as the attribution of a general practitioner to these patients, is of crucial 
importance. 
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1. Introduction 
In the 2015 to 2017 triennium, Portugal had an average life expectancy (ALE1) at birth 
of approximately 81 years-old for the population as a whole. In particular, men were expected 
to live 78 years on average and women obtained a value of 83 years for this measure (NIS, 
2018). When in comparison to data described for the previous period, from 2014 to 2016, these 
values represent a gain of 1,6 months (0,13 years) in ALE for men and one month (0,08 years) 
in ALE for women (refer to Appendix 2 for more information). In the past, infectious diseases 
and its consequent epidemics represented the greatest threats to life of the population and were 
responsible for the highest number of deaths among it (Giddens, 2010). However, according to 
the author, huge advances in both medicine and pharmaceuticals have led to the improvement 
of living conditions, and to relegation of these diseases to a secondary role, offering the lead to 
chronic diseases (CD). As ALE increases, there is a major likelihood for greater Chronic 
Obstructive Pulmonary Disease (COPD) incidence, morbidity and consequent mortality 
(Wang, 2005). When combining Portugal’s ageing problem and the increase in CD prevalence, 
it can further be predicted an increase on the affluence to emergency departments (ED). This 
intensification might be due to higher sensitivity to health-related complications for chronically 
ill patients. Accordingly, it becomes crucial to investigate if the attribution of a general 
practitioner (GP) to patients with CD, and in this case with COPD, can impact the number of 
times these patients visit ED. 
COPD is one of the most common CD, currently the fourth biggest cause of death worldwide, 
and in 2010 it was estimated to have an 11,7% prevalence globally, with more than 384 million 
expected cases (Adeloye, 2015). However, Rodrigues (2018) claimed it is still underdiagnosed 
in the population. It consists in a non-reversible yet preventable disease, that is progressive but 
treatable and portrayed by several symptoms and characteristics (GOLD, 2017). Those include 
                                               
1 Refer to Appendix 1 for all abbreviations. 
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dyspnea (breathing difficulties), muscular fatigue (and intolerance to physical activities), 
coughing and sputum production, with consequent losses in quality-of-life (QoL) and elevated 
mortality rates (GOLD, 2017; Rodrigues, 2018). According to Peces-Barba (2008) and 
Associação Respira (2018), this prognostic originates from airflow obstruction associated with 
alveolar abnormalities due to smoking, the risk factor with principal justification for the 
development of the disease, and or significant exposure to other toxic particles. In fact, the 
disease was responsible for more than 3 million deaths in 2012 (equivalent to 6% of all deaths 
worldwide (GOLD, 2017)), and although the age adjusted mortality is decreasing for other 
leading causes of death, that is not the case for COPD (Pawels, 2001). Estimations forecast it 
will be the third leading cause of death by 2020, as cigarette smoking is growing among younger 
age groups and women (GOLD, 2017). In Portugal, Oliveira (2018-a) declared the burden of 
obstructive lung disease (BOLD) study by Bárbara (2013) estimated, not only the prevalence 
of COPD to be 14,2% in individuals with 40+ years just in Lisbon, but also the disease to be 
amply underdiagnosed (86,8%). In congruence, there is still a suboptimal management of the 
disease that needs to be tackled, including establishing a mandatory diagnostic by spirometry2.  
Throughout their lives, patients with COPD gradually suffer from a decline in health-
condition and consequent QoL, given the considerable symptom encumbrance (Gysels, 2008). 
Due to the challenging management of the disease, as it gains severity, acute exacerbations 
(AE) occur (up to four per patient, per year (Miravittles, 2004)), negatively influencing disease 
progression. In most of the cases, hospitalizations will be required (GOLD, 2017). Currently, 
the global strategy for the diagnosis, management and prevention of COPD (GOLD, 2017), 
defines an AE as “an acute worsening of respiratory symptoms that results in the need for 
additional therapy” (page 33). AE will affect the overall rate of decline in lung function, disease 
                                               
2 Spirometry is the name of a basic pulmonary function test that measures air being expired and inspired. There are three possible measures of 
evaluation and they are either related to volume, time or flow. It is conducted to confirm the presence or absence of lung disease (like COPD) 
quantify lung damage, monitor effects of occupational and environmental exposure and determine results shaped by medication (Moore, 2012). 
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severity, underlying co-morbidities, socio-economic costs and demands on family caregivers 
(Vestbo, 2013), and in consequence, patient QoL. Indeed, COPD progression is highly 
determined by degree of severity and AE frequency. In fact, Seneff (1995) stated that the risk 
of readmission increases in the next year, when COPD patients experience an AE, and a study 
by Osman (1997) has shown readmission rates after AE lead to poor levels of QoL for these 
patients. In accordance, Wilkinson (2004) defended early AE recognition to be critical, as it 
would allow early treatment, faster recovery, reduced hospitalization risk and better QoL. 
According to a review by Jeppesen (2012) on several studies, 25% of COPD patients seen in 
ED can be treated safely and successfully at home, with advantages of fewer readmissions and 
reduced mortality.  
According to Oliveira (2018-b), approaches with or without the recurrence to 
medicines, specific pneumonia and influenza vaccination, immediate respiratory rehabilitation, 
the cessation of smoking habits and physical activity reinforcement, are delineated strategies 
for the prevention of COPD. Moreover, one can speculate that enriched and enhanced 
relationships with GP might possible help in the prevention and control of COPD and its AE. 
According to Murtagh (2011), the vital attributes of a good GP, emerging from a survey 
conducted at St Vincent’s Hospital in Melbourne, were to care, be responsible, concerned, 
competent, knowledgeable, confident, sensible, diligent, and available. Marcinowicz (2013), 
also conducted a study where the author assesses the perceptions of the GP role in health 
promotion for an individual. In it, the patient stated the GP would have a part in the stimulating 
and preventing physical and mental skills of older patients, and in inspiring the development of 
social bonds of patients in their communities. The GP would also be a teacher in regard to 
problems like nutrition, sports, smoking, drinking and handling stress. Gowin (2010) stated GP 
consider the prevention of disease and incipient promotion of health to be crucial features of 
their work. However, they still report several barriers to the effectiveness of their profession, 
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including not enough time, insufficient monetary compensation and massive workload 
(Brotons, 2005). WHO (2008), says the increase in CD prevalence highlights the necessity for 
health systems to adjust to the needs of the population, and the report of the EXpert Panel on 
effective ways of investing in Health (ExPH, 2018) reaffirms the importance of discussing and 
delineating the role of primary health care (PHC). For both, the shift for outpatient care in an 
effective, socially productive and safe way, emphasizing PHC capabilities within health 
prevention, care, promotion, and cure jointly, must be assumed. Given so, it is recommended 
to focus on preventive health policies, improving and increasing capacity and expanding 
resolution in ambulatory care (where PHC is included). Thus, a proper follow-up of these 
individuals in an outpatient setting increases relevance in CD management. Such settings, are 
composed of PHC facilities at center of the health care system, leading to improvements in 
access, quality, and coordination between the different levels of care available in a community. 
In congruence, Atun (2016) defended that, when moving from a Secondary Health Care (SHC) 
centered system, to a preferentially centered on PHC, inefficiencies, admissions and 
hospitalizations of the first can be reduced by the efficiency of the second. In conclusion, 
internments are largely preventable as CD severity can be reduced with adequate management 
after diagnosis and prior to AE, making it possible to enhance better outcomes (Fromer, 2011). 
A better organized system should start with a regular follow up done by GP and end with a 
newly available palliative and supportive care for these patients (Bárbara, 2018). 
The purpose of this study is to understand and evaluate if the attribution of a GP 
influences the number of times a COPD patient goes to the ED, regardless of the motive 
underlying his/her visit.  As so, the aim is to analyze the number of ED visits, with emphasis 
on patients with COPD, and the role of the attributed GP, in Portugal. This work is organized 
in the following way: section 2 presents data and methodology, section 3 presents results and 
discussion, section 4 presents limitations and finally, section 5 presents final remarks. 
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2. Data & Methodology 
The main source of data was provided by ACSS. This database contains properly 
anonymized information in strict compliance with all applicable laws and rules for data 
protection, covering patients that visited ED at least once, in Portugal, for the period comprising 
2014 and/or 2015. Table 1 shows the variables selected for inclusion on the empirical analysis.  
 
Table 1: Variable Identification and Explanation. 
Variable Name Variable Explanation 
Patient Sequence 
Number 
Attributed sequential number to each user in order to anonymize their 
NHS number. 
Age 
User age in the year of the episode. Analyzed as a categorical 
variable: recoded in defined classes 1. [0 - 5], 2. [6 - 18], 3. [19 – 49], 
4. [50 – 64], 5. [65 – 79] and 6. [80+] years-old). 
Gender 
User gender. Can take two values: 1 in case it is female and 0 if it is 
male. 
Attributed GP 
Indicates if the user has an attributed GP when the urgent-episode 
occurred. Can assume two values: 1 in case it is attributed and 0 if it 
is not attributed. 
COPD Presence 
Indicates if the user has COPD at the time of the urgent-episode. Can 
take two values: 1 if the user has the disease or 0 if the user doesn’t 
have it. 
Total nº ED Visits 
Represents the number visits to ED per patient per year. Recoded and 
analyzed in classes (1 - one visit, 2 - two visits, 3 - three visits and 4 - 
four or more visits) for the two different periods (2014 and 2015). 
Year Represents the year of ED admittance. 
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COPD & GP 
Posteriorly developed bi-variate variable, corresponding to patients 
having and attributed GP and COPD simultaneously. 
Generated 
Emergencies (GE) 
Posteriorly developed variable corresponding to the percentage of 
emergencies generated, in volume, per group of patients. 
 
The statistic software STATA (version 14) was utilized with the aim of collecting 
information on (1) the classification of patients in infrequent or frequent users (with a frequent 
user being one that visits an ED four or more times in a year), (2) the portray of this group in 
terms of demographic characteristics, and (3) how the attribution of a GP, the prevalence of 
COPD, or a mix between both, can affect the probability of being a frequent user. In this case, 
probit is the particular statistical method used. This model runs on the basis that, given a 
determined event of binary outcome, there may be several other events, that might predict its 
outcome. In a simple way, the outcome can be explained or predicted by other variables (IDRE, 
2018). Given a patient that went to an ED at least once, what is his/her probability of being a 
frequent user? A probit model is estimated to provide an answer to this question. 
To know the impact caused by the different independent variables on the probability of 
being a frequent ED user (the binary outcome variable), this project is based on data capturing 
the population that went to an ED for 2014 and/or 2015. In this study, the size of the population 
corresponded to 3 052 437 ED users for 2014, 3 064 574 ED users for 2015 and to a total of 
6 117 011 ED users when analyzing the population for both years. Table 2 shows the 
distribution of the independent variables in both relative and absolute terms. 
 
Table 2: Gender, Attributed General Practitioner, Chronic Obstructive Pulmonary Disease and 
Age-Group distribution among the population, per year, and respective Generated Emergencies 
percentage. 
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Nº Users % Users % GE 
2014 2015 2014 2015 2014 2015 
Gender 
Female    1 680 952     1 680 645  55,1 54,8 56,7 56,5 
Male    1 371 485     1 383 929  44,9 45,2 43,3 43,5 
Attributed 
GP 
Yes    2 639 248     2 659 108  86,5 86,8 86,4 87,4 
No       413 189        405 466  13,5 13,2 13,6 12,6 
COPD 
Yes         52 527          58 270  1,7 1,9 2,4 2,6 
No    2 999 910     3 006 304  98,3 98,1 97,6 97,4 
Age 
Groups 
(Years) 
0 to 5       327 293        318 711  10,7 10,4 9,6 10,0 
6 to 18       429 002        434 065  14,1 14,2 12,8 13,3 
19 to 49    1 088 506     1 083 034  35,7 35,3 13,9 13,9 
50 to 64       494 319        500 922  16,2 16,3 14,8 14,6 
65 to 79       455 928        460 222  14,9 15,0 16,7 16,2 
80 +       257 310        267 602  8,4 8,7 32,2 32,0 
 
3. Results & Discussion  
Table 3 shows user distribution and the correspondent GE percentage for each year, in 
accordance to their respective number of ED visits. 
Table 3: Patient distribution according to their number of Emergency Department visits 
per year, and correspondent Generated Emergencies percentage. 
Nº of ED Visits 
per Year 
Nº of Users % Users % GE 
2014 2015 2014 2015 2014 2015 
1 1 703 560 1 721 672 55,8 56,2 14,2 14,2 
2 659 766 658 800 21,6 21,5 21,3 21,3 
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3 304 270 302 503 10,0 9,9 30,7 30,8 
4 384 841 381 599 12,6 12,5 33,8 33,7 
Total 3 052 437 3 064 574 100 100 100 100 
 
When looking to Table 3, it is possible to see that more than half (>50%) of ED users 
only made one ED visit in a year, for both years (55,8% and 56,2% for 2014 and 2015 
respectively). Moreover, frequent users correspond to 12,6% of the population under scrutiny 
for 2014 and 12,5% for 2015. However, when the focus lies on GE percentage, these values are 
not as small. In fact, the 12,6% and 12,5% frequent users are responsible for approximately 
34% of GE for both 2014 and 2015, whereas the more than half ED users that only went once 
to an ED in a year, were responsible for 14,2% of GE. These results clearly demonstrate that 
there is a group of patients, the now known frequent users, utilizing the ED in an excessive 
manner and consequently creating a health care service disequilibrium. 
Table 4 now shows coefficient and standard error results, for every estimated model. 
Moreover, it clearly highlights which results are statistically significant and which are not, as 
well as not applicable operations and reference group identification for each model. Graph 1 
shows the resulting impact on the probability of being a frequent user, caused by the age 
variable and each of its specific age-groups.  
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Graph 1: Scatter plot on the impact, caused by each of the different age-groups, on the 
probability of being a frequent when analyzing the population in general.  
 
Focusing on Model 1: Both Table 4 and Graph 1 indicate all age-groups have lower 
probabilities of being frequent users when compared against the reference group. This 
corresponds to the expected results on one side, as parents tend to be more cautious and 
preventive with younger children, and on the other side, contradicts expectations regarding 
highest values of ED usage by elder groups. The first probably happens because, within the 
reference group, patients cannot communicate their level of illness in a perfectly understandable 
manner, leading caregivers to visit an ED even if just for precaution. As so, this behavior cannot 
be of their responsibility, being adults the ones who make these decisions. Then, the results 
regarding elderly stop being contradictory if we exclude the children, once the 80+ age group 
comes in second place regarding the higher chance to be an ED frequent user. In fact, both 
results are in line with reality. The 0 to 5 years-old age-group, represents individuals who face 
higher environmental susceptibility to disease not only because their immune, reproductive, 
digestive and central-nervous systems are still developing, but also because their behaviors are 
more likely to put their health condition at risk (WHO, 2018). Moreover, although patients with 
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65 or more years of age are less likely to be frequent users when compared to children, they are 
still more likely to visit ED than all other age-groups. As we know, users in the extremes of the 
age bar, are typically the ones with a higher sensibility. Krieg (2016), stated individuals with 
75 years of age or more have a higher tendency to frequently recur to an ED, which we can 
partly confirm by the results in this table. As so, these groups have higher tendencies to recur 
to health care, children with undeveloped systems and elders with increases in CD prevalence, 
such as COPD. Regarding gender, females have 2,2 percentage points increase in the 
probability of being frequent users when compared to males. In fact, Hansagi (2001) had 
already confirmed that, although the small difference, females would have a higher probability 
of being frequent ED users. Considering GP attribution, the analysis showed this variable not 
to be statistically significant, meaning the attribution of a GP did not affect the probability of 
being a frequent user, given the patient went at least once to an ED in 2014/2015. This result 
was unexpected, as there is a propensity to think a patient with an assigned GP will have a lower 
tendency to recur to an ED. As results do not support this premise, nor the contrary, there is no 
conclusion regarding the influence of the attribution of a GP caused on the probability of being 
a frequent user, when a patient has already been to the ED once. Focusing on COPD presence, 
having it positively impacts the probability of being a frequent user by 10 percentage points. 
As a respiratory tract illness that can, and typically leads to AE, COPD propitiates situations 
that drive users to ED in order to more promptly and efficiently solve these difficult situations 
(Higginson, 1989). When looking at the combined variable (having COPD & an attributed GP), 
the attribution of a GP to patients with COPD in the general population negatively impacts their 
probability of being frequent users by 1,1 percentage points. Although small, this result 
demonstrates that for at least 1,1% of COPD patients, the attribution of a GP can diminish the 
number of times they visit ED in a year. In translation, when compared to patients who suffer 
from COPD and don’t have an attributed GP, the ones who suffer from this disease and are 
 14 
accompanied in PHC have a decrease of 1,1 percentage points in the probability of being 
frequent ED users. Finally, the year variable is measuring the influence caused by aspects that 
have changed from one year to the other, and have not been modelized. Model 1 shows that 
from one year to the other, a patient will have a lower probability of being a frequent user by 
0,13 percentage points. Assuming the present is 2014, in 2015 a user will be less likely to be a 
frequent user by 0,13% due to these non-modelized aspects that changed from 2014 to 2015. 
 
Focusing on Model 2: This analysis comprehended a sample including users having 
COPD in 2014 and not having an attributed GP for that same year but being attributed one in 
2015. This resulted in a sample with 6 554 observations. In regard to age, the program excludes 
observations for the age-groups comprising individuals between 0 and 18 years of age, as they 
represent a group with rare COPD prevalence and consequent considerably small number of 
patients. As so, Model 2 comprehends an analysis conducted on a sample of 19 or more years-
old patients that went at least once to an ED. Users between 65 and 79 years-old have a 4.9 
percentage points increase in the probability of being frequent users, and individuals belonging 
to the 80+ years-old age-group have an increase in this probability by 10 percentage points. 
Both predicted in the literature, as these two age-groups comprise users more susceptible to 
complications of the disease (AE), and have higher sensibility to other co-morbidities 
(Guimarães, 2016). Consequently, they are more likely to experience emergency episodes and 
have higher tendencies to make ED visits (Krieg, 2016), when compared to individuals that 
also have COPD but belong to the reference group. Regarding gender, being female negatively 
impacts the probability of being frequent user by 2,3 percentage points. This result although 
contradicting the one for Model 1, comes into accordance with the literature. As stated by 
Bárbara (2013), when COPD affects the two genders, men are more likely to visit an ED than 
women as the disease also demonstrates higher prevalence among men. Model 2 also shows a 
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positive impact of 4,0 percentage points on the probability under analysis, for COPD patients 
that don’t have an attributed GP in 2014 and are attributed one in 2015. This was surprising, 
once it shows that having an attributed GP by 2015 actually increases the number of ED visits 
these patients do (when compared to patients suffering from the same disease and not having 
an attributed GP). As there is an inclination to consider the opposite, meaning a patient with an 
assigned GP will have a lower propensity to recur to an ED (Wang, 2005), three scenarios can 
be conjectured in order to justify this result: (1) these patients comprised the most severe cases 
of the disease in 2014 and as so, they were attributed a GP to help deal with the disease by 
2015. However, this does not produce results in time for us to see a change in the influence of 
this attribution. The disease has already progressed to a high severity level and the GP needs to 
refer these patients from PHC to SHC anyway (Rowe, 2018); (2) these patients are not satisfied 
with PHC or have difficulties in accessing it and they have been trying to get this care through 
SHC anyway (Oliveira, 2006); (3) these frequent COPD users in SHC are likely to be frequent 
users in PHC as well (Hansagi, 2001). Thus, GP attribution to these patients does not influence 
their behavior in ED. However, there is no information available to make this distinction 
possible. In regard to year, the non-modelized aspects do not impact the probability of being a 
frequent user in a statistically significant way, meaning that from one year to the other, there 
were no significant (non-modelized) changes influencing this probability. 
 
Focusing on Model 3: This model comprehends an analysis where the sample 
comprised users who didn’t suffer from any type of CD in 2014, didn’t have an attributed GP 
for that same year, but were attributed a GP in 2015. This separation resulted in a sample with 
429 449 observations. In regard to age, Model 3 shows that, for patients with no chronic 
conditions, there is a decrease in ED usage for all age-groups, when patients were attributed a 
GP. Once more, these results are in accordance to the literature, showing GP attribution 
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produces an impact, reducing the number of times these patients visit ED. Regardless of age, 
this possibility for follow-up in PHC clearly impacts ED visit behavior. For all age-groups 
under analysis, the attribution of a GP lead to the reduction in ED usage in a statistically 
significant way. In terms of gender, being female positively impacts the probability under study 
by 3,2 percentage points, given both genders are freed of CD (also in accordance to previously 
stated information). Model 3 shows an increase of 0,9 percentage points in the probability of a 
patient without CD being a frequent user, when he/she doesn’t have an attributed GP in 2014 
and is attributed one in 2015. Surprisingly, this result shows that having a GP by 2015 increases 
the number of ED visits these patients make, when compared to patients in the same conditions 
but without an assigned physician. Speculation can come in place once again, as these patients 
might comprise the most severe cases of the non-chronically-ill population in 2014 and as so, 
they were attributed a GP to help cooperate with these episodes in 2015. However, as for model 
2, there is no information available to allow this analysis. Regarding year, non-modelized 
aspects impact the probability of being a frequent user and cause an increase on it by 4,7 
percentage points, meaning that from one year to the other, there were changes, influencing this 
probability for non-CD-patients. 
 
Focusing on Model 4: The model shows an analysis comprising users that have COPD 
and an assigned GP in 2014 but stop having a GP in 2015. Model 4 indicates results for a sample 
where the total number of observations was 4 950. Unfortunately, the impact caused by all the 
variables evaluated in Table 4 for Model 4, on the probability of being a frequent user, was 
found not to be statistically significant. This means none of the variables affect the probability 
of a COPD patient being a frequent user, when he/she has a GP in 2014 and loses it in 2015. 
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Focusing on Model 5: In this case, the model shows the impact on ED usage, caused 
by having and attributed GP in 2014 and losing it in 2015, in a population with no CD of any 
sort. This resulted in a sample with 240 956 observations. In regard to age, there are negative 
impacts in the probability of being a frequent user for all age-groups, which contradicts the 
results obtained for model 3. Here, the loss in PHC follow-up reduces de probability of these 
users being frequent ED visitors. This means that patients who lose their GP by 2015 end up 
visiting the ED less often. However, both results can be congruent if we speculate that this 
negative impact on the probability under analysis results from follow-up cessation for the 
healthier cases that do not need this accompaniment anymore. When analyzing gender, being a 
female positively impacts, by 3,0 percentage points, the probability of being a frequent ED user. 
Focusing on year, non-modelized aspects impact the probability of non-CD patients being 
frequent users, causing an increase of 0,6 percentage points on it, when they have an attributed 
GP in 2014 and lose it the next year. This means that from one year to the other, the loss of GP 
follow-up, positively influenced the probability of non-CD patients having to visit an ED. 
 
4. Limitations 
 
As in a considerable amount of studies conducted until today, there are potential 
limitations in this investigation requiring careful interpretation of the results. Data 
heterogeneity and the immense population size under consideration may have caused a bias of 
the results. Moreover, the inexistence of a variable expressing neither the motif, symptom or 
condition underlying ED admittance, nor the care pathway these patients had undergone before, 
might also have compromised a more thorough behavioral analysis of the COPD patients in 
question. In this sense, although it is known if the patients suffer from the disease, it is neither 
recognized if their ED visits were related with this fact, nor if their behavior before visiting an 
ED comprehended a visit to PHC. The creation of such variable would allow the precise 
quantification of ED admissions for patients with COPD, visiting ED due to this fact. 
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Furthermore, would permit the analysis of the characteristics enhancing or diminishing visit 
frequency. Finally, as there is no prior study, conducted in Portugal, with the same 
characteristics or the same purpose of investigation, the validity of the obtained results might 
also be constrained. Although the clear acknowledgement of these potential limitations, it is 
likely that these analyses are useful in the preliminary discovery of this research question, given 
the population size. In the future, it is crucial to include the prior health care path of the patient, 
and as already suggested by Aguiar (2016), the follow-up in PHC and ED visits as well. For 
this to be possible, it will be necessary to implement a system that allows the collection of data 
in these aspects of the NHS. 
 
5. Final Remarks 
The accomplishment of this study gains special relevance in the area of respiratory 
diseases due to the scarcity of studies on this subject in Portugal, the increasingly evident 
problem of attendance to ED, the difficulties in accessing health care, and the need to implement 
strategies that make services more efficient (all already mentioned by Aguiar (2016)). Focusing 
on a disease that is increasingly prevalent and debated, this study seeks to characterize patients 
with COPD by testing which factors, within a range of possibilities, contribute to frequent ED 
usage by these patients. In this context, and answering the focal question leading this project, it 
is possible to conclude what the profile of a COPD user who seeks an ED more often is, and 
more importantly, if GP attribution influences this behavior. After analysis and discussion of 
the obtained results, it is now feasible to indicate whether or not there is a correlation between 
the allocation of a GP and the frequency of ED visit by this group of users. In consequence, 
these patients could be the target of governmental health-related policies that could reduce their 
ED recurrence, given, for example, the opportunity to experience better follow-up in PHC. 
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Statistics show a COPD population that had at least one visit to the ED with 55 thousand 
patients on average (for each year), where women have a lower tendency to be frequent ED 
users and 59,7% patients are men. In fact, these results are supported by the literature, and the 
probit model estimations. From the results, women are more likely to be frequent users in the 
general and non-CD populations (positive impacts of 2,2 and 3,2/3,0 percentage points in this 
probability, respectively), whereas they are less likely to be frequent ED users within the COPD 
sample (negative impact of 2,3 percentage points in this probability). Regarding age-group 
analysis, among the general population, 0 to 5 years-old individuals are the ones visiting the 
ED more often. On the other extreme of the age bar, 80+ years-old patients are the second group 
to visit the ED more frequently. More importantly, as discussed for non-CD-populations, GP 
attribution clearly impacts age-group behavior towards ED usage, whether by diminishing the 
number of visits when a GP is attributed to these patients (Model 3 in Table 4) or reducing ED 
usage when GP accompaniment is lost (Model 4 in Table 4). Although causality is not 
understood in this project, speculation can come in place. As so, these two contradictory results 
might be explained with good follow-up for the most severe cases in PHC for the first case 
(Model 3 in Table 4), and no need for follow-up given the reach to a healthy patient status in 
the second (Model 4, Table 4). Nonetheless, both results further justify the need for studies on 
this matter. On the other hand, GP attribution in the COPD population has been shown to 
positively impact the probability of being a frequent user, causing an increase in ED usage by 
4,0 percentage points (Model2 in Table 4). As a puzzling result, once it contradicts the expected 
one (better follow-up health care = lower propensity to visit ED), this outcome makes its 
underlying justifications relevant for further study. COPD patients already have a higher 
propensity to be frequent users, independently of their age, given they suffer from CD. It can 
now be conjectured these results are probably correlated with patient illness severity and 
associated co-morbidities. As reinforced by the literature, COPD prevalence and AE frequency 
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tends to increase with disease progression, which is typically related with age progression. 
Bering this in mind, COPD patients will have increasing needs for health care access as they 
age, and their disease progresses. However, causality is also not understood in this case, 
although several hypotheses have been formulated on section 4, Model 2. 
In a succinct way, when patients suffer from COPD, it is possible to affirm that the 
impact on the probability of being a frequent user, caused by: (1) age, results in increased ED 
usage, especially for individuals with 80+ years-old; (2) gender, results in increased ED usage 
for men, as there is a higher prevalence of the disease among them, they are also more 
susceptible to be frequent ED users; (3) GP attribution, results in increased ED usage.  
As the purpose of this study is to find if the attribution of a GP influences the number 
of times a COPD patient goes to the ED, regardless of the motive underlying his/her visit, an 
answer can now be provided. Truth is, GP attribution influences ED usage for COPD patients, 
even if the result is the opposite of expected (increases usage instead of reducing it). The reasons 
behind this behavior are still unclear, although some conjectures have been made on section 4, 
Model 2. Those include a possible inverted causality result, meaning that the coefficient of the 
variable regarding GP attribution captures high severity cases, having an attributed GP and 
going to the ED more often. In fact, this ends up producing a stronger effect than the one 
resulting from a good GP-patient follow-up.  
In accordance, this study has provided important information to support further research 
studies exploring causality for COPD patients’ ED usage behavior. Moreover, it brings 
contributions towards the improvement of disease knowledge and treatment in PHC and SHC, 
as well as towards the increase of new innovative ways of efficiently improving life and health-
related conditions for these patients by developing prevention, control and monitoring strategies 
for COPD patients. It is then suggested that all patients be early assigned a GP, with special 
emphasis on the allocation of these professionals to patients with greater vulnerability, although 
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further studies are needed to more precisely evaluate the potential impact of such measure. 
Indeed, on can speculate that early GP attribution to COPD patients, guaranteeing enriched and 
meaningful follow-up in PHC, might drive different results in ED usage behavior for these 
patients. Not only in this group, but throughout the population, this suggestion corresponds to 
a solution that is capable of providing special attention and easier access to health care, and 
better QoL for citizens “now” monitored in PHC, thus reducing the need to resort to SHC 
services. 
Finally, and given not only the changes we have been experiencing, but also the ones 
yet to come, I would like to conclude on a personal thought: The time has come for us to develop 
a perspective of life revolving around prevention medicine, as there is no doubt, the curable 
way of looking at it is already outdated. 
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7. Appendices 
 
Appendix 1 – Table 1. All abbreviations. 
 
AE Acute Exacerbation(s). GP General Practitioner(s). 
ALE Average Life Expectancy. NHS National Health Service. 
BOLD Burden of Obstructive Lung Disease. NIS National Institute of Statistics. 
CD Chronic Disease(s). PHC Primary Health Care. 
COPD 
Chronic Obstructive Pulmonary 
Disease. 
QoL 
Quality of Life 
ED Emergency Department(s). SHC Secondary Health Care 
GE Generated Emergencies. WHO World Health Organization.  
GOLD Global Initiative for Chronic Obstructive Lung Disease. 
 
 
Appendix 2 - Table 2. Portugal’s Average Life Expectancy (ALE) at birth from the 2012-2014 
triennium to the 2015-2017 triennium (NIS, 2018). 
 
Triennium 
ALE (Years) 
General Average Men Women 
2012-2014 80,24 77,16 83,03 
2013-2015 80,41 77,36 83,23 
2014-2016 80,62 77,61 83,33 
2015-2017 80,78 77,74 83,41 
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